Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity: In this entry-level role, you will work within our Translational Medicine group supporting the computational workflows for the analysis, interpretation, and visualization of biomarker data from our clinical trial samples. In particular, you will perform rigorous quality control checks to confirm the accuracy and integrity of data throughout the entirety of the analysis pipeline. This position requires extensive collaboration with biomarker scientists and other computational biologists. Required Skills, Experience and Education:
Preferred Skills:
This is a contract position that will be employed through a third-party recruiting agency. The agency will provide the pay range, which will be based on several factors, including job-related skills, experience, market conditions, and relevant education or training.